首页> 外文期刊>Diseases of the Colon and Rectum >Tumor deposit is a poor prognostic indicator for patients who have stage II and III colorectal cancer with fewer than 4 lymph node metastases but not for those with 4 or more
【24h】

Tumor deposit is a poor prognostic indicator for patients who have stage II and III colorectal cancer with fewer than 4 lymph node metastases but not for those with 4 or more

机译:对于患有II期和III期结直肠癌且淋巴结转移少于4个的患者而言,肿瘤沉积是不良的预后指标,但对于4个或更多的患者则不是

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Extranodal tumor deposits are involved in TNM classification. However, it is uncertain whether a tumor deposit is a regular lymph node metastasis, and its prognostic significance in patients with stage II or II colorectal cancer remains to be established. OBJECTIVE: This study aimed to determine the prognostic significance of tumor deposits for stage II and II colorectal cancer. DESIGN: This study is a retrospective review of clinicopathological data. SETTING: This study was conducted at a tertiary care hospital/referral center in Japan. PATIENTS: We reviewed the clinical course of 171 stage II and 173 stage II consecutive patients between January 1999 and December 2006. MAIN OUTCOME MEASURES: We examined the clinicopathological features of colorectal cancers with tumor deposits and calculated overall survival and recurrence-free survival of the patients according to the status of tumor deposits. The primary outcome was the impact of tumor deposits on patient survival. RESULTS: Thirty-five (10.2%) patients with colorectal cancers had tumor deposits in the pericolic and/or mesocolic region. Survival rates among the patients with tumor deposits were significantly lower than those without (5-year overall survival: 58.4% vs 81.0%, p < 0.0001; 5-year recurrence-free survival: 47.1% vs 73.4%, p < 0.0001). Tumor deposit was an independent prognostic factor for patients with colorectal cancer in multivariate analysis (overall survival: HR, 2.30; 95% CI, 1.264.04; p = 0.04; recurrence-free survival: HR, 2.42; 95% CI, 1.044.90; p = 0.04). Tumor deposit was an independent prognostic factor in N0 and N1 colorectal cancer, whereas N2 cancer had poor survival outcome regardless of tumor deposit. LIMITATIONS: Our study was a single-institution retrospective study, and the numbers of patients were relatively small to draw firm conclusions. CONCLUSION: Tumor deposit may be an independent adverse prognostic factor for stage II and II N1 colorectal cancer.
机译:背景:结外肿瘤沉积物参与TNM分类。然而,尚不确定肿瘤沉积是否为正常的淋巴结转移,其在II期或II期结直肠癌患者中的预后意义尚待确定。目的:本研究旨在确定肿瘤沉积物对II期和II期大肠癌的预后意义。设计:本研究是对临床病理数据的回顾性回顾。地点:这项研究是在日本的三级医院/转诊中心进行的。患者:我们回顾了1999年1月至2006年12月之间连续171例II期和173例II期患者的临床病程。主要观察指标:我们检查了具有肿瘤沉积物的结直肠癌的临床病理特征,并计算了该患者的总体生存率和无复发生存率。患者根据肿瘤的沉积状况。主要结果是肿瘤沉积物对患者生存的影响。结果:35例(10.2%)结直肠癌患者的肿瘤沉积在周周和/或中周区。有肿瘤沉积物的患者的生存率显着低于没有肿瘤沉积物的患者(5年总生存率:58.4%对81.0%,p <0.0001; 5年无复发生存率:47.1%对73.4%,p <0.0001)。在多变量分析中,肿瘤沉积是大肠癌患者的独立预后因素(总生存率:HR,2.30; 95%CI,1.264.04; p = 0.04;无复发生存率:HR,2.42; 95%CI,1.044。 90; p = 0.04)。肿瘤沉积是N0和N1大肠癌的独立预后因素,而无论肿瘤沉积如何,N2癌症的生存结果均较差。局限性:我们的研究是单机构回顾性研究,患者人数相对较少,无法得出肯定的结论。结论:肿瘤沉积可能是II期和II期N1大肠癌的独立不良预后因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号